Invasive breast carcinoma - IARC

1323. Jacques SM, Qureshi F, Ramirez NC,
Malviya VK, Lawrence WD (1997). Tumors
of the uterine isthmus: clinicopathologic
features and immunohistochemical characterization
of p53 expression and hormone
receptors. Int J Gynecol Pathol 16:
38-44.
1324. Jaffe R, Altaras M, Bernheim J, Ben
Aderet N (1985). Endocervical stromal sar -
coma--a case report. Gynecol Oncol 22:
105-108.
1325. Jafri NH, Niemann TH, Nicklin JL,
Copeland LJ (1998). A carcinoid tumor of
the broad ligament. Obstet Gynecol 92: 708.
1326. Jain AN, Chin K, Borresen-Dale AL,
Erikstein BK, Eynstein LP, Kaaresen R,
Gray JW (2001). Quantitative analysis of
chromosomal CGH in human breast tumors
associates copy number abnormalities
with p53 status and patient survival. Proc
Natl Acad Sci USA 98: 7952-7957.
1327. Jain S, Fisher C, Smith P, Millis RR,
Rubens RD (1993). Patterns of metastatic
breast cancer in relation to histological
type. Eur J Cancer 29A: 2155-2157.
1328. Jakubowska A, Narod SA, Goldgar
DE, Mierzejewski M, Masojc B, Nej K,
Huzarska J, Byrski T, Gorski B, Lubinski J
(2003). Breast Cancer Risk Reduction
Associated with the RAD51 Polymorphism
among Carriers of the BRCA1 5382insC
Mutation in Poland. Cancer Epidemiol
Biomarkers Prev 12: 457-459.
1329. Jamal AA (2001). Pattern of breast
diseases in a teaching hospital in Jeddah,
Saudi Arabia. Saudi Med J 22: 110-113.
1330. Jamal S, Mushtaq S, Malik IA, Khan
AH, Mamoon N (1994). Malignant tumours
of the male breast - a review of 50 cases. J
Pak Med Assoc 44: 275-277.
1331. James BA, Cranor MI, Rosen PP
(1993). Carcinoma of the breast arising in
microglandular adenosis. Am J Clin Pathol
100: 507-513.
1332. James K, Bridger J, Anthony PP
(1988). Breast tumour of pregnancy ('lactating'
adenoma). J Pathol 156: 37-44.
1333. James LA, Mitchell EL, Menasce L,
Varley JM (1997). Comparative genomic
hybridisation of ductal carcinoma in situ of
the breast: identification of regions of DNA
amplification and deletion in common with
invasive breast carcinoma. Oncogene 14:
1059-1065.
1334. Janin N, Andrieu N, Ossian K, Lauge
A, Croquette MF, Griscelli C, Debre M,
Bressac-de-Paillerets B, Aurias A, Stoppa-
Lyonnet D (1999). Breast cancer risk in
ataxia telangiectasia (AT) heterozygotes:
haplotype study in French AT families. Br J
Cancer 80: 1042-1045.
1335. Janvoski NA, Paramanandhan TL
(1973). Ovarian Tumors. Tumors and tumorlike
conditions of the ovaries, fallopian
tubes and ligaments of the uterus. Major
problems in obstetrics and gynecology.
WB Sauders: Philadelphia.
1336. Japaze H, Van Dinh T, Woodruff JD
(1982). Verrucous carcinoma of the vulva:
study of 24 cases. Obstet Gynecol 60: 462-
466.
1337. Jauniaux E, Nicolaides KH, Hustin J
(1997). Perinatal features associated with
placental mesenchymal dysplasia.
Placenta 18: 701-706.
1338. Jee KJ, Kim YT, Kim KR, Kim HS, Yan
A, Knuutila S (2001). Loss in 3p and 4p and
gain of 3q are concomitant aberrations in
squamous cell carcinoma of the vulva.
Mod Pathol 14: 377-381.
1339. Jensen ML, Kiaer H, Andersen J,
Jensen V, Melsen F (1997). Prognostic
comparison of three classifications for
medullary carcinomas of the breast.
Histopathology 30: 523-532.
1340. Jensen ML, Kiaer H, Melsen F (1996).
Medullary breast carcinoma vs. poorly dif -
ferentiated ductal carcinoma: an immunohistochemical
study with keratin 19 and
oestrogen receptor staining.
Histopathology 29: 241-245.
1341. Jensen ML, Nielsen MN (1989).
Broad ligament mucinous and serous cystadenomas
of borderline malignancy. Acta
Obstet Gynecol Scand 68: 663-667.
1342. Jensen ML, Nielsen MN (1990).
Broad ligament mucinous cystadenoma of
borderline malignancy. Histopathology 16:
89-91.
1343. Jensen PA, Dockerty MB, Symmonds
RE, Wilson RB (1966). Endometrioid sarcoma
("stromal endometriosis"). Report of 15
cases including 5 with metastases. Am J
Obstet Gynecol 95: 79-90.
1344. Jensen RD, Norris HJ, Fraumeni JF
Jr. (1974). Familial arrhenoblastoma and
thyroid adenoma. Cancer 33: 218-223.
1345. Jensen V, Jensen ML, Kiaer H,
Andersen J, Melsen F (1997). MIB-1
expression in breast carcinomas with
medullary features. An immunohistological
study including correlations with p53 and
bcl-2. Virchows Arch 431: 125-130.
1346. Jeon HJ, Akagi T, Hoshida Y, Hayashi
K, Yoshino T, Tanaka T, Ito J, Kamei T,
Kawabata K (1992). Primary non-Hodgkin
malignant lymphoma of the breast. An
immunohistochemical study of seven
patients and literature review of 152
patients with breast lymphoma in Japan.
Cancer 70: 2451-2459.
1347. Jernstrom H (2001). Breast-feeding
and the Risk of Breast Cancer in BRCA1
and BRCA2 Carriers. Am J Hum Genet 69:
9.
1348. Jernstrom H, Lerman C, Ghadirian P,
Lynch HT, Weber B, Garber J, Daly M,
Olopade OI, Foulkes WD, Warner E, Brunet
JS, Narod SA (1999). Pregnancy and risk of
early breast cancer in carriers of BRCA1
and BRCA2. Lancet 354: 1846-1850.
1349. Jhala DN, Atkinson BF, Balsara GR,
Hernandez E, Jhala NC (2001). Role of DNA
ploidy analysis in endometrial adenocarci -
noma. Ann Diagn Pathol 5: 267-273.
1350. Jiao YF, Nakamura S, Oikawa T,
Sugai T, Uesugi N (2001). Sebaceous gland
metaplasia in intraductal papilloma of the
breast. Virchows Arch 438: 505-508.
1351. Johannsson O, Loman N, Borg A,
Olsson H (1998). Pregnancy-associated
breast cancer in BRCA1 and BRCA2
germline mutation carriers. Lancet 3 5 2 :
1359-1360.
1352. Johannsson OT, Idvall I, Anderson C,
Borg A, Barkardottir RB, Egilsson V, Olsson
H (1997). Tumour biological features of
BRCA1-induced breast and ovarian cancer.
Eur J Cancer 33: 362-371.
1353. Johannsson OT, Ranstam J, Borg A,
Olsson H (1998). Survival of BRCA1 breast
and ovarian cancer patients: a populationbased
study from southern Sweden. J Clin
Oncol 16: 397-404.
1 3 5 4 . Johnson AD, Hebert AA, Esterly NB
(1986). Nevoid basal cell carcinoma syndrome:
bilateral ovarian fibromas in a 3 1/2-
year-old girl. J Am Acad Dermatol 14: 371-374.
1355. Johnson TL, Kumar NB, White CD,
Morley GW (1986). Prognostic features of
vulvar melanoma: a clinicopathologic
analysis. Int J Gynecol Pathol 5: 110-118.
1356. Jones D.B. (1955). Florid papillomatosis
of the nipple ducts. Cancer 8: 315-319.
1357. Jones C, Damiani S, Wells D,
Chaggar R, Lakhani SR, Eusebi V (2001).
Molecular cytogenetic comparison of
apocrine hyperplasia and apocrine carcinoma
of the breast. Am J Pathol 158: 207-
214.
1358. Jones C, Merrett S, Thomas VA,
Barker TH, Lakhani SR (2003). Comparative
genomic hybridization analysis of bilateral
hyperplasia of usual type of the breast. J
Pathol 199: 152-156.
1359. Jones HW, III (1999). The importance
of grading in endometrial cancer. Gynecol
Oncol 74: 1-2.
1360. Jones HW, III, Droegemueller W,
Makowski EL (1971). A primary melanocarcinoma
of the cervix. Am J Obstet Gynecol
111: 959-963.
1361. Jones MA, Mann EW, Caldwell CL,
Tarraza HM, Dickersin GR, Young RH
(1990). Small cell neuroendocrine carcino -
ma of Bartholin's gland. Am J Clin Pathol
94: 439-442.
1362. Jones MA, Young RH, Scully RE
(1991). Diffuse laminar endocervical glandular
hyperplasia. A benign lesion often
confused with adenoma malignum (minimal
deviation adenocarcinoma). Am J
Surg Pathol 15: 1123-1129.
1363. Jones MW, Kounelis S, Papadaki H,
Bakker A, Swalsky PA, Woods J,
Finkelstein SD (2000). Well-differentiated
villoglandular adenocarcinoma of the uterine
cervix: oncogene/tumor suppressor
gene alterations and human papillomavirus
genotyping. Int J Gynecol Pathol
19: 110-117.
1 3 6 4 . Jones MW, Norris HJ (1995).
Clinicopathologic study of 28 uterine
leiomyosarcomas with metastasis. Int J
Gynecol Pathol 14: 243-249.
1365. Jones MW, Norris HJ, Snyder RC
(1989). Infiltrating syringomatous adenoma
of the nipple. A clinical and pathological
study of 11 cases. Am J Surg Pathol 13:
197-201.
1366. Jones MW, Silverberg SG, Kurman
RJ (1993). Well-differentiated villoglandular
adenocarcinoma of the uterine cervix: a
clinicopathological study of 24 cases. Int J
Gynecol Pathol 12: 1-7.
1367. Jones MW, Tavassoli FA (1995).
Coexistence of nipple duct adenoma and
breast carcinoma: a clinicopathologic
study of five cases and review of the literature.
Mod Pathol 8: 633-636.
1368. Jones PA, Laird PW (1999). Cancer
epigenetics comes of age. Nat Genet 21:
163-167.
1369. Jones RW, Rowan DM (1994). Vulvar
intraepithelial neoplasia III: a clinical study
of the outcome in 113 cases with relation
to the later development of invasive vulvar
carcinoma. Obstet Gynecol 84: 741-745.
1 3 7 0 . Jordan LB, Abdul-Kader M, al
Nafussi A (2001). Uterine serous papillary
carcinoma: histopathologic changes within
the female genital tract. Int J Gynecol
Cancer 11: 283-289.
1371. Joseph RE, Enghardt MH, Doering
DL, Brown BF, Shaffer DW, Raval HB
(1992). Small cell neuroendocrine carcino -
ma of the vagina. Cancer 70: 784-789.
1372. Joshi MG, Lee AK, Pedersen CA,
Schnitt S, Camus MG, Hughes KS (1996).
The role of immunocytochemical markers
in the differential diagnosis of proliferative
and neoplastic lesions of the breast. Mod
Pathol 9: 57-62.
1373. Jozefczyk MA, Rosen PP (1985).
Vascular tumors of the breast. II.
Perilobular hemangiomas and hemangiomas.
Am J Surg Pathol 9: 491-503.
1374. Julien M, Trojani M, Coindre JM
(1994). [Myofibroblastoma of the breast.
Report of 8 cases]. Ann Pathol 14: 143-147.
1375. Junge J, Horn T, Bock J (1989).
Primary malignant Schwannoma of the
uterine cervix. Case report. Br J Obstet
Gynaecol 96: 111-116.
1376. Kaaks R (1996). Nutrition, hormones,
and breast cancer: is insulin the missing
link? Cancer Causes Control 7: 605-625.
1377. Kaaks R, Lundin E, Manjer J, Rinaldi
S, Biessy C, Soderberg S, Lenner P, Janzon
L, Riboli E, Berglund G, Hallmans G (2002).
Prospective study of IGF-I, IGF-binding
proteins and breast cancer risk, in northern
and southern Sweden. Cancer Causes
Control 13: 307-316.
1378. Kachel G, Bornkamm GW, Hermanek
P, Kaduk B, Schricker KT (1980). [Burkitt
lymphoma of African type in Europe
(author's transl)]. Dtsch Med Wochenschr
105: 413-417.
1 3 7 9 . Kader HA, Jackson J, Mates D,
Andersen S, Hayes M, Olivotto IA (2001).
Tubular carcinoma of the breast: a population-based
study of nodal metastases at
presentation and of patterns of relapse.
Breast J 7: 8-13.
1380. Kaern J, Trope CG, Kristensen GB,
Abeler VM, Pettersen EO (1993). DNA
ploidy; the most important prognostic factor
in patients with borderline tumors of the
ovary. Int J Gynecol Cancer 3: 349-358.
1381. Kahanpaa KV, Wahlstrom T, Grohn P,
Heinonen E, Nieminen U, Widholm O
(1986). Sarcomas of the uterus: a clinicopathologic
study of 119 patients. Obstet
Gynecol 67: 417-424.
1382. Kahner S, Ferenczy A, Richart RM
(1975). Homologous mixed Mullerian
tumors (carcinosarcomal) confined to
endometrial polyps. Am J Obstet Gynecol
121: 278-279.
1383. Kainu T, Juo SH, Desper R, Schaffer
AA, Gillanders E, Rozenblum E, Freas-Lutz
D, Weaver D, Stephan D, Bailey-Wilson J,
Kallioniemi OP, Tirkkonen M, Syrjakoski K,
Kuukasjarvi T, Koivisto P, Karhu R, Holli K,
Arason A, Johannesdottir G, Bergthorsson
JT, Johannsdottir H, Egilsson V,
Barkardottir RB, Johannsson O,
Haraldsson K, Sandberg T, Holmberg E,
Gronberg H, Olsson H, Borg A, Vehmanen
P, Eerola H, Heikkila P, Pyrhonen S,
Nevanlinna H (2000). Somatic deletions in
hereditary breast cancers implicate 13q21
as a putative novel breast cancer susceptibility
locus. Proc Natl Acad Sci USA 97:
9603-9608.
1384. Kairouz R, Clarke RA, Marr PJ,
Watters D, Lavin MF, Kearsley JH, Lee CS
(1999). ATM protein synthesis patterns in
sporadic breast cancer. Mol Pathol 52:
252-256.
1385. Kajii T, Ohama K (1977). Androgenetic
origin of hydatidiform mole. Nature 268:
633-634.
1386. Kajiwara M, Toyoshima S, Yao T,
Tanaka M, Tsuneyoshi M (1999). Apoptosis
and cell proliferation in medullary carcinoma
of the breast: a comparative study
between medullary and non-medullary
carcinoma using the TUNEL method and
immunohistochemistry. J Surg Oncol 70:
209-216.
References 393